Conditional RNAi: Towards a silent gene therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sang-Kyung | - |
dc.contributor.author | Kumar, Priti | - |
dc.date.accessioned | 2022-12-20T21:44:39Z | - |
dc.date.available | 2022-12-20T21:44:39Z | - |
dc.date.created | 2022-08-26 | - |
dc.date.issued | 2009-07 | - |
dc.identifier.issn | 0169-409X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/176578 | - |
dc.description.abstract | RNA interference (RNAi) has the potential to permit the downregulation of virtually any gene. While transgenic RNAi enables stable propagation of the resulting phenotype to progeny, the dominant nature of RNAi limits its use to applications where the continued suppression of gene expression does not disturb normal cell functioning. This is of particular importance when the target gene product is essential for cell survival, development or differentiation. It is therefore desirable that knockdown be externally regulatable. This review is aimed at providing an overview of the approaches for conditional RNAi in mammalian systems, with a special mention of studies employing these approaches to target therapeutically/biologically relevant molecules, their advantages and disadvantages, and a pointer towards approaches best suited for RNAi-based gene therapy. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER | - |
dc.title | Conditional RNAi: Towards a silent gene therapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Sang-Kyung | - |
dc.identifier.doi | 10.1016/j.addr.2009.03.016 | - |
dc.identifier.scopusid | 2-s2.0-65749112775 | - |
dc.identifier.wosid | 000267255900015 | - |
dc.identifier.bibliographicCitation | ADVANCED DRUG DELIVERY REVIEWS, v.61, no.7-8, pp.650 - 664 | - |
dc.relation.isPartOf | ADVANCED DRUG DELIVERY REVIEWS | - |
dc.citation.title | ADVANCED DRUG DELIVERY REVIEWS | - |
dc.citation.volume | 61 | - |
dc.citation.number | 7-8 | - |
dc.citation.startPage | 650 | - |
dc.citation.endPage | 664 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | INDUCIBLE SHRNA EXPRESSION | - |
dc.subject.keywordPlus | INTERFERENCE | - |
dc.subject.keywordPlus | SYSTEM | - |
dc.subject.keywordPlus | KNOCKDOWN | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | PROMOTER | - |
dc.subject.keywordPlus | VECTORS | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordPlus | RECOMBINATION | - |
dc.subject.keywordPlus | TRANSCRIPTION | - |
dc.subject.keywordAuthor | Conditional RNAi | - |
dc.subject.keywordAuthor | Inducible RNAi | - |
dc.subject.keywordAuthor | Transgenic RNAi | - |
dc.subject.keywordAuthor | Cre/loxP | - |
dc.subject.keywordAuthor | Tetracycline inducible system | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0169409X09001409?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.